Invention Grant
- Patent Title: Selective VPAC2 receptor peptide agonists
- Patent Title (中): 选择性VPAC2受体肽激动剂
-
Application No.: US12508584Application Date: 2009-07-24
-
Publication No.: US07897573B2Publication Date: 2011-03-01
- Inventor: Bengt Krister Bokvist , Lianshan Zhang , Jorge Alsina-Fernandez
- Applicant: Bengt Krister Bokvist , Lianshan Zhang , Jorge Alsina-Fernandez
- Applicant Address: US IN Indianapolis
- Assignee: Eli Lilly and Company
- Current Assignee: Eli Lilly and Company
- Current Assignee Address: US IN Indianapolis
- Agent Andrea M. Castetter
- Main IPC: A61K38/16
- IPC: A61K38/16
Abstract:
The present invention encompasses peptides that selectively activate the VPAC2 receptor and are useful in the treatment of diabetes.
Public/Granted literature
- US20100009916A1 SELECTIVE VPAC2 RECEPTOR PEPTIDE AGONISTS Public/Granted day:2010-01-14
Information query
IPC分类:
